Investors & Media Value through vision

ProQR scientist in the lab

Located in Leiden, Netherlands and Cambridge, Mass., ProQR Therapeutics (Nasdaq:PRQR) is a biotechnology company developing RNA therapies for the treatment of severe rare and common diseases. We focus on advancing our proprietary Axiomer® RNA-editing platform technology.

Corporate presentation

View the latest ProQR corporate presentation

Internal link Download presentation

ProQR Corporate Presentation

Events

A list of past and future conferences and events

Where to meet us

Financial information

Latest SEC filings, annual reports and AGM documents

Financial information icon

Presentations and publications

The latest scientific publications for our development programs

View scientific publications

presentations and publications icon

Corporate governance

Documents related to corporate governance

Go to documents

corporate governance icon

Analysts

A list of the analysts that cover ProQR

ProQR Share Performance

View $PRQR share performance

Press Releases

Internal link ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
Date: 22 December 2022
Internal link Lilly and ProQR to Expand RNA Editing Collaboration
Date: 22 December 2022
Internal link ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022
Date: 14 November 2022

Internal link More press releases

Female scientist working in the lab